2010-04-06
Vinge advises Active Biotech on directed new share issue
The biotechnology company, Active Biotech (NASDAQ OMX Stockholm) is carrying out a directed new issue of shares for approximately SEK 149 million to funds managed by Sectoral Asset Management Inc. Vinge is acting for Active Biotech.
Vinge’s team consists of Erik Sjöman and Christian Lindhé.